Endothelial Dysfunction in the Development of Aortic Degeneration, Dissection, and Rupture
主动脉变性、夹层和破裂中的内皮功能障碍
基本信息
- 批准号:10662568
- 负责人:
- 金额:$ 66.21万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-07-15 至 2026-06-30
- 项目状态:未结题
- 来源:
- 关键词:AneurysmAngiotensin IIAortaAortic DiseasesApoptosisAttentionBloodCardiovascular DiseasesCause of DeathCell DeathCellsCellular AssayCessation of lifeChromatinChromatin Remodeling FactorDNADNA DamageDataDevelopmentDiseaseDisease ProgressionDissectionElastic FiberEndothelial CellsEndotheliumEnhancersEpigenetic ProcessEventExtravasationFunctional disorderGenesHigh Fat DietHumanIRF3 geneImageIn VitroInfiltrationInflammationInflammatoryInflammatory InfiltrateInfusion proceduresInterferon ActivationInvestigationKnockout MiceLifeLinkLyticMedialMediatingMicrodissectionMissionModelingMolecularMusNational Heart, Lung, and Blood InstitutePathogenesisPathway interactionsPatientsPermeabilityPharmaceutical PreparationsPopulationPreventionProtein Kinase InteractionPublic HealthRIPK1 geneReceptor Up-RegulationResearchRoleRuptureSMARCA4 geneSeriesSignal PathwaySignal TransductionSmooth Muscle MyocytesSting InjuryStressTBK1 geneTestingThoracic Aortic AneurysmTransposaseUnited StatesUp-RegulationWild Type Mousecell injurycontrast enhanced computed tomographyendothelial dysfunctionepigenomicsexperimental studyin vivoinhibitorinsightmouse modelnanoparticlenovelpreventprogramspromoterreceptor upregulationsensorsingle-cell RNA sequencingtherapeutic targettranscription factortranscriptomics
项目摘要
PROJECT SUMMARY
Ascending thoracic aortic aneurysms and dissections (ATAAD) are extremely lethal diseases. The contribution
of endothelial dysfunction in ATAAD has received limited attention and thus remains poorly understood. Com-
pelling evidence from our preliminary studies suggests a critical role for endothelial cell (EC) injury and endo-
thelial hyperpermeability in aortic degeneration and ATAAD development. [scRNA-seq analysis of aortas from
sporadic ATAAD patients revealed significant EC dysfunction with upregulation of RIP3 and GSDMD that trig-
ger necroptosis and pyroptosis, respectively. In a sporadic ATAAD mouse model, aortic challenge with high-
fat diet and angiotensin II infusion induced RIP3 and GSDMD in ECs, caused endothelial hyperpermeability,
nanoparticle infiltration, interlaminar space expansion, elastic fiber delamination, and microdissection. EC-Rip3-
/- or EC-Gsdmd-/- showed markedly reduced nanoparticle infiltration and aortic degeneration.] Further investiga-
tion with scATAC-seq showed that aortic challenge increased chromatin accessibility at promoters/enhancers
of the pro-inflammatory/pro-death genes, likely by activating pro-inflammatory transcription factors (TFs) such
as IRF3. In human ECs, cytosolic DNA and STING-TBK1 signaling was a potent upstream trigger for the acti-
vation of IRF3 and BRG1 and induction of GSDMD expression. The objective of this application is to test the
central hypothesis that aortic stress activates inflammatory signaling within ECs that triggers epigenetic in-
duction of a pro-inflammatory and pro-death program, leading to EC necroptosis/pyroptosis, barrier dysfunc-
tion, blood component infiltration, aortic wall degeneration, and ATAAD formation. [Aim 1 will test the hypothe-
sis that RIP3-mediated EC necroptosis and GSDMD-mediated EC pyroptosis compromise EC barrier function,
thereby facilitating the infiltration of inflammatory blood components and promoting aortic degeneration and
ATAAD formation. In our sporadic ATAAD model, we will compare aortic degeneration and ATAAD formation
in control mice, EC-Rip3-/- mice, EC-Gsdmd-/- mice, and WT mice treated with a necroptosis/pyroptosis inhibi-
tor.] Aim 2 will test the hypothesis that aortic stress activates inflammatory signaling (e.g., STING pathway)
within ECs that triggers epigenetic induction of a pro-inflammatory and pro-death program. We will perform
scRNA-seq and scATAC-seq analyses of ECs in aortas from unchallenged and challenged WT mice and EC-
specific Sting KO mice. Aim 3 will test the hypothesis that stress signals (e.g., cytosolic DNA) trigger sensing-
signaling pathways (e.g., STING-TBK) that directly activates chromatin remodeling complexes (e.g.,
BRG1/SWI/SNF) and TFs (e.g., IRF3) that induce GSDMD expression and promote EC pyroptosis. We will test
the hypothesis in cultured human ECs (Aim 3A) and [confirm the mechanistic links in human ATAAD aortas
(Aim 3B)]. We expect that the proposed studies will provide novel insight into the molecular mechanisms of
sporadic aortic degeneration and ATAAD formation, which will in turn enable development of new treatments
for preventing disease progression and its fatal sequelae.
1
项目摘要
胸升主动脉瘤和夹层(ATAAD)是非常致命的疾病。的贡献
ATAAD中的内皮功能障碍受到的关注有限,因此仍然知之甚少。COM-
我们初步研究的有力证据表明,内皮细胞(EC)损伤和内皮细胞凋亡在内皮细胞损伤中起着关键作用。
主动脉变性和ATAAD发展中的上皮通透性过高。[来自大肠杆菌的大肠杆菌的scRNA-seq分析]
散发性ATAAD患者表现出显著的EC功能障碍,RIP 3和GSDMD上调,
格尔坏死性凋亡和胃灼热性凋亡。在散发性ATAAD小鼠模型中,用高浓度-
高脂饮食和血管紧张素II输注诱导EC中的RIP 3和GSDMD,引起内皮通透性过高,
纳米颗粒渗透、层间空间膨胀、弹性纤维分层和显微切割。EC-Rip3-
/-或EC-Gsdmd-/-显示显著减少的纳米颗粒浸润和主动脉变性。此外,
与scATAC-seq的比较显示,主动脉激发增加了启动子/增强子处的染色质可及性,
促炎/促死亡基因,可能是通过激活促炎转录因子(TF),
IRF3。在人类EC中,胞浆DNA和STING-TBK 1信号传导是激活的有效上游触发因素。
IRF 3和BRG 1的表达和GSDMD表达的诱导。本申请的目的是测试
主动脉应激激活内皮细胞内的炎症信号传导,从而触发表观遗传损伤的中心假设
诱导促炎和促死亡程序,导致EC坏死性凋亡/焦亡,屏障功能障碍,
血管壁变性、血液成分浸润、主动脉壁变性和ATAAD形成。[Aim 1.测试hypothe--
RIP 3介导EC坏死性凋亡和GSDMD介导的EC焦亡损害EC屏障功能,
从而促进炎性血液成分的浸润并促进主动脉变性,
ATAAD编队。在我们的散发性ATAAD模型中,我们将比较主动脉变性和ATAAD形成
在对照小鼠中,EC-Rip 3-/-小鼠、EC-Gsdmd-/-小鼠和用坏死性凋亡/焦亡性凋亡抑制剂处理的WT小鼠,
(tor.)目的2将检验主动脉应激激活炎症信号传导的假设(例如,STING途径)
在内皮细胞内触发促炎和促死亡程序的表观遗传诱导。我们将执行
来自未攻击和攻击的WT小鼠和来自未攻击和攻击的WT小鼠的大肠杆菌中EC的scRNA-seq和scATAC-seq分析。
特异性Sting KO小鼠目标3将检验压力信号(例如,胞质DNA)触发传感-
信号通路(例如,STING-TBK),其直接激活染色质重塑复合物(例如,
BRG 1/SWI/SNF)和TF(例如,IRF 3),其诱导GSDMD表达并促进EC焦亡。我们将测试
在培养的人EC中的假设(目的3A)和[证实了人ATAAD细胞中的机制联系
(Aim 3B)]。我们希望这些研究将为我们提供新的见解,
散发性主动脉变性和ATAAD形成,这反过来将有助于开发新的治疗方法
用于预防疾病进展及其致命后遗症。
1
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KETAN B Ghaghada其他文献
KETAN B Ghaghada的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KETAN B Ghaghada', 18)}}的其他基金
Endothelial Dysfunction in the Development of Aortic Degeneration, Dissection, and Rupture
主动脉变性、夹层和破裂中的内皮功能障碍
- 批准号:
10539531 - 财政年份:2022
- 资助金额:
$ 66.21万 - 项目类别:
PHARMACOKINETICS OF LIPOSOMAL-IODINATED CONTRAST AGENTS IN MICE-MICRO-CT
脂质体碘化造影剂在小鼠显微 CT 中的药代动力学
- 批准号:
8363173 - 财政年份:2011
- 资助金额:
$ 66.21万 - 项目类别:
PHARMACOKINETICS OF LIPOSOMAL-IODINATED CONTRAST AGENTS IN MICE--MICRO-CT
脂质体碘化造影剂在小鼠体内的药代动力学--Micro-CT
- 批准号:
8171598 - 财政年份:2010
- 资助金额:
$ 66.21万 - 项目类别:
PHARMACOKINETICS OF LIPOSOMAL-IODINATED CONTRAST AGENTS IN MICE--MICRO-CT
脂质体碘化造影剂在小鼠体内的药代动力学--Micro-CT
- 批准号:
7956941 - 财政年份:2009
- 资助金额:
$ 66.21万 - 项目类别:
相似海外基金
Early endothelial function activation by angiotensin II receptor blockers prevents vascular damage in a model of diabetes
血管紧张素 II 受体阻滞剂早期激活内皮功能可预防糖尿病模型中的血管损伤
- 批准号:
493141 - 财政年份:2023
- 资助金额:
$ 66.21万 - 项目类别:
Clinical benefits and mechanism of action of angiotensin-II receptor blocker on Cardiovascular remodeling in patients with repaired coarctation of aorta
血管紧张素II受体阻滞剂对主动脉缩窄修复患者心血管重塑的临床疗效及作用机制
- 批准号:
10734120 - 财政年份:2023
- 资助金额:
$ 66.21万 - 项目类别:
Role of Angiotensin II in Bladder Dysfunction
血管紧张素 II 在膀胱功能障碍中的作用
- 批准号:
10707997 - 财政年份:2022
- 资助金额:
$ 66.21万 - 项目类别:
Regulation of nuclear calcium and ROS by Angiotensin II in heart cells. Régulation du calcium et ROS nucléaires par l'angiotensine II dans les cellules cardiaques.
血管紧张素 II 对心脏细胞中核钙和 ROS 的调节。
- 批准号:
RGPIN-2016-04414 - 财政年份:2022
- 资助金额:
$ 66.21万 - 项目类别:
Discovery Grants Program - Individual
Role of Angiotensin II in Bladder Dysfunction
血管紧张素 II 在膀胱功能障碍中的作用
- 批准号:
10555926 - 财政年份:2022
- 资助金额:
$ 66.21万 - 项目类别:
Regulation of nuclear calcium and ROS by Angiotensin II in heart cells. Régulation du calcium et ROS nucléaires par l'angiotensine II dans les cellules cardiaques.
血管紧张素 II 对心脏细胞中核钙和 ROS 的调节。
- 批准号:
RGPIN-2016-04414 - 财政年份:2021
- 资助金额:
$ 66.21万 - 项目类别:
Discovery Grants Program - Individual
Targeting cancer-associated fibroblasts and tumour hypoxia with angiotensin II receptor blockers
使用血管紧张素 II 受体阻滞剂靶向癌症相关成纤维细胞和肿瘤缺氧
- 批准号:
445961 - 财政年份:2021
- 资助金额:
$ 66.21万 - 项目类别:
Operating Grants
Intratubular Angiotensin II and AT1a Receptors in The Proximal Tubules: Roles in Hypertension and Kidney Injury
近曲小管中的管内血管紧张素 II 和 AT1a 受体:在高血压和肾损伤中的作用
- 批准号:
10164776 - 财政年份:2020
- 资助金额:
$ 66.21万 - 项目类别:
Novel Roles of Mitochondrial Angiotensin II in The Proximal Tubule of The Kidney
线粒体血管紧张素 II 在肾近端小管中的新作用
- 批准号:
10251271 - 财政年份:2020
- 资助金额:
$ 66.21万 - 项目类别:
Protection and organ injury by angiotensin II treatment for septic shock
血管紧张素II治疗感染性休克的保护作用和器官损伤
- 批准号:
20K09284 - 财政年份:2020
- 资助金额:
$ 66.21万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




